Trinity Biotech | TRIB - Ordinary Share Capital


Trinity Biotech reported $385.2M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
EDAP TMS EUR 37.39M 0 Sep/2025
J&J USD 2.41B 1.74M Dec/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 780.74M 6.33M Dec/2025
Surmodics USD 14.3M 13.58M Jun/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Tosoh JPY 307.89M 2.47M Mar/2026
Trinity Biotech USD 385.2M 382.82M Jun/2025
Veracyte USD 79.79M 743K Mar/2026